Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/ Randomized Phase II Trial Of Oxaliplatin (NSC #266046) With Or Without ZD 1839 (NSC # 715055) In Patients With Advanced Colorectal Carcinoma

NCT00026299 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.

NCT NCT00026299
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00026299 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/ Randomized Phase II Trial Of Oxaliplatin (NSC #266046) With Or Without ZD 1839 (NSC # 715055) In Patients With Advanced Colorectal Carcinoma
Lead sponsor
University of Chicago
Phase
Phase 1/2
Overall status
Completed
Start date
September 30, 2001
Completion date
February 28, 2005
Enrollment
14 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer